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a b s t r a c t
Introduction: Otorhinolaryngological manifestations of rheumatologic diseases represent a 
great challenge not only to the generalistphysician but also to the ENT doctor andrheu-
matologist. They often represent early manifestations of an autoimmune disorder which 
requires prompt and aggressive immunosuppressive treatment. Auditory, nasal, laryngeal 
and eye symptoms can be the first manifestation of rheumatic diseases and their proper 
assessment helps the doctor to identify signs of disease activity. The objective of this study 
is to identify the ENT manifestations in patients with rheumatic diseases in a high comple-
xity hospital, regarding facilitating an early diagnosis and treatment.
Methods: We performed clinical and complete otorhinolaryngological evaluations in pa-
tients selected from the outpatient rheumatology in a standardized manner by the use of a 
standardized form filling during the secondhalf of 2010.
Results: In the study group, systemic lupus erythematosus (SLE) patients had predomi-
nantly laryngeal manifestations, while patients with Sjögren’s syndrome showed a higher 
prevalence of otologic manifestations. Changes in audiometric tests were found in 53% 
of Wegener’s granulomatosis (WG) patients, 80% of relapsing polychondritis (RP), 33% of 
systemic lupus erythematosus (SLE) and 50% of Churg-Strauss syndrome (SCS). Regarding 
nasal alterations, these were found so prevalent in all conditions, especially Churg-Strauss 
syndrome.
Discussion and conclusion: This study demonstrated that most patients treated in our hospi-
tal has the ENT signs and symptoms commonly associated in previous studies on rheuma-
tic diseases, but further studies with a larger number of patients must be made to establish 
such relations.
© 2014 Sociedade Brasileira de Reumatologia. Published by Elsevier Editora Ltda. 
All rights reserved.
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r e s u m o
Introdução: As manifestações otorrinolaringológicas de doenças reumáticas representam 
um grande desafio não só ao médico generalista, mas também ao otorrinolaringologista 
e ao reumatologista. Frequentemente representam manifestações iniciais de uma desor-
dem autoimune que exige um tratamento imunossupressor imediato e agressivo. Sinto-
mas auditivos, nasais, laríngeos e oculares podem ser a primeira manifestação de doenças 
reumáticas, e sua correta avaliação auxilia o médico a identificar sinais de atividade da 
doença. O objetivo deste trabalho foi identificar as manifestações otorrinolaringológicas 
em pacientes com doenças reumáticas em um hospital de alta complexidade, no que se 
refere a facilitar diagnóstico e tratamento precoces.
Métodos: Foram realizadas avaliações clínicas e otorrinolaringológicas completas em paci-
entes selecionados no ambulatório de reumatologia, no segundo semestre do ano de 2010, 
de forma padronizada e com utilização de um formulário de preenchimento normatizado.
Resultados: No grupo estudado, pacientes com LES apresentaram predominantemente 
manifestações laríngeas, enquanto pacientes com síndrome de Sjögren apresentaram pre-
domínio das manifestações otológicas (100% dos casos). As alterações de exames audiomé-
tricos são encontradas em 53% dos casos portadores de GW, 80% de PR, 33% de LES e 50% de 
SCS. Quanto às alterações nasais, estas foram encontradas de forma prevalente em todas 
as patologias, principalmente a síndrome de Churg-Strauss.
Discussão e conclusão: Este estudo demonstrou que a maioria dos pacientes em seguimento 
em nosso serviço apresenta os sinais e sintomas otorrinolaringológicos comumente rela-
cionados em trabalhos prévios sobre doenças reumáticas, porém novos estudos com um 
número maior de pacientes devem ser feitos para comprovar tais relações
© 2014 Sociedade Brasileira de Reumatologia. Publicado por Elsevier Editora Ltda. 
Todos os direitos reservados.
Introduction
Rheumatic diseases have a high prevalence rate worldwide 
and a representative functional disability index.1 These con-
ditions comprise a heterogeneous group of entities that 
produce systemic changes involving the connective tissue 
throughout the body. For this reason they may involve blood 
vessels and serous and mucous membranes of all the aerodi-
gestive tract.2 The treatment itself of such diseases with 
non-steroidal anti-inflammatory drugs can cause symptoms 
in many patients.3 In this sense, much has been discussed 
about the current ENT manifestations in patients with rheu-
matic diseases.4
Ear, nasal, laryngeal and ocular symptoms may be the 
first manifestations of various rheumatic diseases, as re-
lapsing polychondritis (RP), systemic lupus erythematosus 
(SLE), Wegener’s granulomatosis (WG), Sjögren’s syndrome 
(SS) and Churg-Strauss syndrome (CSS),5,6 and this combi-
nation is described in several trials. As an example, there 
are some case reports of patients with RP in which changes 
in pinna, nasal cartilage, nasal septum, larynx and trachea 
were found, causing dysphonia, dyspnea and cosmetic de-
formities.7,8 Allergic rhinitis, chronic sinusitis and serous oti-
tis media are commonly found in patients with CSS,9 while 
immunological abnormalities are frequently found in pa-
tients with Menière’s disease.10 Sensorineural hearing loss 
may be the first manifestation of polyarteritis nodosa,11 as 
well as recurrent parotitis for SS12 and chronic otitis media 
for ankylosing spondylitis.13
Given the global growth of rheumatic diseases, driven by 
population ageing and exposure to a larger number of induc-
ers of autoimmune changes,14 the identification of ENT symp-
toms in these patients can become an important tool for the 
diagnosis and, consequently, for the early treatment of such 
diseases. The correct evaluation of rheumatic conditions, par-
ticularly in SLE, helps the physician to identify signs of dis-
ease activity, which directly affects the patients’ quality of life 
and their prognosis.15-17
Thus, the objective of this work is to identify ENT mani-
festations in patients with rheumatic diseases in a hospital 
of high complexity. As this trial was conducted in 2010 and 
considering the fact that the old nomenclature for rheuma-
tologic diseases is more widespread in our environment, we 
used this nomenclature in the present trial. In the new no-
menclature established by the Chapel Hill Consensus in 2012, 
Wegener’s granulomatosis became known as granuloma-
tous with polyangiitis, and Churg-Strauss syndrome became 
known as eosinophilic granulomatous with polyangiitis.18
Materials e methods
In all patients, complete clinical and ENT evaluations consist-
ing of a detailed history, a thorough ENT physical examination 
and audiometry, imitanciometry (acoustic impedance) and 
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nasofiberlaryngoscopy were performed. Sensorineural hearing 
loss or sound discrimination impairment with bilateral and 
symmetrical occurrence and with subacute evolution were 
considered as audiometric alterations.
The assessment was fully standardized, and a normatized 
filling form was used during the second half of 2010.
For the selection of patients, we requested from the De-
partment of Rheumatology a random referral of patients for 
specialized ENT evaluation, but some specific outpatient ser-
vices contributed more to the project (such as vasculitis and 
Wegener’s granulomatosis outpatient services). 
The first five patients in each outpatient rheumatology 
should have been referred for a period of 15 days. 
Every patient evaluation was performed at the otorhinolar-
yngology ambulatory of our national reference, tertiary care, 
university hospital. The patients were attended and evaluated 
by two otolaryngologists randomly selected among the profes-
sionals who participated in this trial. 
The criteria used were those of the Otorhinolaryngologist 
available at the time and who would perform the patient’s as-
sessment.
This trial was evaluated and approved by the Research 
Ethics Committee from our institution (Opinion CEP/FCM nº 
1187/2011).
Results
Thirty-two selected patients of Rheumatology Discipline Out-
patient Clinic (HC/FCM/UNICAMP) were evaluated. In the eval-
uated sample , the patients were diagnosed as defined by the 
criteria of Medical Guidelines of the Brazilian Society of Rheu-
matology19 for SLE and by the American College of Rheumatol-
ogy20,21,22,23 for other diseases, with a diagnosis established for 
one from five rheumatic diseases: Wegener’s granulomatosis 
(WG), Churg-Strauss syndrome (CSS), relapsing polychondritis 
(RP), Sjögren’s syndrome (SS) and systemic lupus erythemato-
sus (SLE). 
The mean age of the participants was 41.7 years (range 22-
70 years) and the mean disease duration was 9.12 years (range 
1-40 years).
1 – Wegener’s granulomatosis (n = 17) 
Among WG patients, nine (53.1%) reported hearing loss and 
had low tone threshold results at audiometry. The most fre-
quent type of reduction was that of a bilateral sensorineu-
ral pattern, present in five patients (55.6%). In the context 
of rhinologic symptoms, nasal obstruction in 11 (64.8%) and 
rhinorrhea in ten (58.8%) patients were the most prevalent 
symptoms, with compatible changes present in the rhino-
scopic exam in 12 (70.2 %) of these patients, and the most 
frequent symptoms were coryza, septal perforations, muco-
sal oedema and turbinate hypertrophy. Complaints related 
to the larynx, dyspnea and raucousness were found in six 
(35.2%) and seven (41.2%) patients, respectively, being the 
most prevalent complaints. Of these, seven (41.2%) patients 
had an abnormal physical examination, for instance, hyper-
aemia of posterior pharynx, inter-arytenoidal oedema and 
relative degrees of subglottic stenosis (Table 1).
2 – Recidivant polychondritis (n = 5) 
In patients with RP, among the otologic symptoms, the most 
frequent complaint was ear itching in three patients (60%), 
followed by tinnitus, hearing loss and ear fullness in two 
(40%). The changes more often found during the physical 
examination were pinna oedema and opacity of the tym-
panic membrane. The main nasosinusal symptoms were: 
presence of nasal obstruction, rhinorrhea and sneezing, re-
ported by two patients (40%), and coryza, mucosal oedema, 
pale mucosa, granulation of the turbinates and turbinate 
hypertrophy were the primary findings. As to laryngeal 
complaints, cough, foreign body sensation, raucousness 
and choking were present in two cases (40%). The chang-
es found on physical examination were inter-arytenoidal 
oedema, paresis of vocal folds and laryngeal hyperaemia 
(Table 2).
3 – Sjögren’s syndrome (n = 5) 
For patients with SS, tinnitus and ear fullness were present in 
three and four of the five patients, respectively; the most fre-
quent changes were in conductive hearing loss and presence 
of a large amount of desquamation in the external auditory ca-
nal. Nasal obstruction was present in all patients. In the rhino-
scopic examination, hyperaemia and oedema of mucosa were 
the observed findings. Dysphonia and raucousness were the 
only reported laryngeal symptoms; and the signs found were 
salivary gland hypertrophy, dry mouth and inter-arytenoidal 
oedema (Table 3).
Table 1 – Presence of otological signs and symptoms 
Wegener’s 
granulomatosis n = 17
Relapsing 
Polychondritis n = 5
Syndrome of 
Sjögren n = 5 
Systemic Lupus 
Erythematosus n = 3
Syndrome of 
Churg-Strauss n = 2 
Otalgia 8 (47%) 1 (20%) 0 0 0
Otorrhea 4 (23%) 0 1 (20%) 0 0
Tinnitus 7 (41%) 2 (40%) 3 (60%) 1 (33%) 1 (50%)
Ear fullness 3 (18%) 2 (40%) 4 (80%) 0 1 (50%)
Hearing loss 9 (53%) 2 (40%) 2 (40%) 1 (33%) 1 (50%)
Hyperacusis 0 0 0 0 0
Ear pruritus 3 (18%) 3 (60%) 5 (100%) 0 0
Dizziness 1 (6%) 0 1(20%) 0 0
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4 – Systemic Lupus Erythematosus (n = 3) 
Among SLE patients, tinnitus and hearing loss were reported 
by one patient (33%), with presence of left ear sensorineural 
hearing loss and right ear conducive hearing loss. Among 
nasal symptoms, nasal obstruction and rhinorrhea were 
also  present in one patient, and edema and coryza were the 
signs most often found . Dysphonia was present in two cases 
(67%), and the presence of glottic cleft during phonation and 
inter-arytenoidal oedema were the changes observed.
5 – Churg-Strauss syndrome (n = 2) 
One patient (50%) with Churg-Strauss reported tinnitus, ear 
fullness and hearing loss, with conductive hearing loss at 
audiometry. At rhinoscopy, pale mucosa, turbinate hypertro-
phy and coryza were observed in patients. The complaints of 
dysphonia, cough, dyspnea, haemoptysis, and raucousness 
were compatible with the presence of oedema of laryngeal 
mucosa, glottic cleft and secretion, observed during the ex-
amination of the larynx.
In the evaluation of all the symptoms studied by region, 
all SS patients reported the presence of at least one otologic 
or nasal symptom, and also had audiometric change. Laryn-
geal symptoms were more frequent in patients with SLE, being 
present in two patients (66%) (Table 4); however, patients with 
SLE were those with fewer ear and nasal symptoms, or with 
audiometric changes. These conditions were present in only 
one patient (33%) (Tables 5 and 6).
The audiometric changes (indicated in Table 6) found were de-
scribed as sensorineural hearing loss (SNHL), conductive hearing 
loss (CHL) or mixed hearing loss (MHL). In the case of SNHL, the 
following distribution was observed: 29% of WG, 60% of PR, 20% of 
SJ, 33% of SLE and 0% of CSS. With MHL, no cases were observed. 
On the other hand, for CHL another distribution was observed: 
23% of WG, 20% of PR, 80% of SJ, 33% of SLE and 50% of CSS.
Discussion
ENT manifestations in autoimmune diseases represent a di-
agnostic challenge for the rheumatologist, otolaryngologist 
and clinician.1,5,15,24,25 Generally, ENT symptoms may represent 
an early sign of an undiagnosed autoimmune disorder that 
often requires an immediate and aggressive immunosup-
pressive treatment.25-29 There are diseases of systemic action 
that present themselves with localized manifestations, and 
the region of the head and neck is an important site of these 
manifestations.5
Ear damage have been occasionally reported as a com-
plication in the course of several rheumatic diseases.8,30 It is 
common, for example, to find sensorineural hearing loss with 
decreased hearing acuity or discrimination of sounds. Uni- or 
bilateral sensorineural hearing loss affecting medium and high 
frequencies have been reported in patients with SLE, and there 
is evidence of a strong association between hearing loss and 
Table 2 – Presence of nasal signs and symptoms
Wegener’s 
granulomatosis n = 17 
Relapsing 
Polychondritis n = 5 
Syndrome of 
Sjögren n = 5
Systemic Lupus 
Erythematosus n = 3 
Syndrome of 
Churg-Strauss n = 2 
Relapsing 
polychondritis 
11 (65%) 2 (40%) 5 (100%) 1 (33%) 1 (50%)
Nasal 
obstruction 
10 (59%) 2 (40%) 2 (40%) 1 (33%) 1 (50%)
Rhinorrhea 6 (35%) 0 4 (80%) 0 1 (50%)
Nasal itching 6 (35%) 0 2 (40%) 0 1 (50%)
Hyposmia 2 (12%) 0 0 0 0
Anosmia 1 (6%) 0 0 0 0
Cacosmia 5 (29%) 0 1 (20%) 0 1 (50%)
Postnasal drip 7 (41%) 2 (40%) 1 (20%) 0 2 (100%)
Table 3 – Aerodigestive pathways/pharyngal symptoms
Wegener’s 
granulomatosis n = 17 
Relapsing 
Polychondritis n = 5 
Syndrome of 
Sjögren n = 5 
Systemic Lupus 
Erythematosus n = 3 
Syndrome of 
Churg-Strauss n = 2 
Dysphonia 3 (14%) 1 (20%) 2 (40%) 2 (67%) 1 (50%)
Cough 4 (23%) 2 (40%) 0 0 1 (50%)
Snoring 0 0 0 0 0
Foreign body 
sensation 
1 (6%) 2 (40%) 0 0 0
Dysphagia 0 0 0 0 0
Odynophagia 0 0 0 0 0
Dyspnea 6 (35%) 1 (20%) 0 1 (33%) 1 (50%)
Hemoptysis 1 (6%) 0 0 0 1 (50%)
Hawk 7 (41%) 2 (40%) 3 (60%) 0 1 (50%)
Heartburn 1 (6%) 1 (20%) 2 (40%) 0 0
Gagging 1 (6%) 2 (40%) 0 0 0
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elevated titres of anticardiolipin antibodies. A sensorineural 
hearing loss in the course of Sjögren’s syndrome (SS) is partly 
attributed to the presence of high titres of those antibodies.4 
A sudden or gradual hearing loss may occur in about 50% of 
patients with recidivant polychondritis, and both in these as 
in patients with WG, a conductive hearing loss is the main oto-
logic damage. According to literature, audiovestibular deficits 
are uncommon in patients with CSS.4 According to the findings 
of this trial, ear manifestations in the patients studied confirm 
the literature data, maintaining statistical similarity.
In literature we find data on vestibulocochlear system in-
volvement by vascular lesions in the internal auditory artery, 
causing sensorineural dysacusis in addition to symptoms 
such as dizziness and tinnitus. According to the authors, the 
little mention of vestibular symptoms is due to the fact that 
the gradual involvement of the vestibular system promotes 
labirynthic compensation.31 
Laryngeal involvement is extremely rare and the symp-
toms can range from hoarseness to respiratory distress.32 
Smith et al. published two cases with cricoarytenoid ulcer-
ation, stenosis and oedema. Kraus and Guerra-Bautista   pub-
lished a case with complete vocal fold paralysis in 1990. Tietel 
et al. published, in 1997, a review of cases of laryngeal involve-
ment in SLE, in which laryngeal oedema occurred in 28% of 
cases and vocal paralysis in 11%.32
Allergic rhinitis is often present in patients with Churg-
Strauss syndrome.4 Symptoms such as nasal itching, airflow 
obstruction, coryza and recurrent sinusitis are common man-
ifestations in CSS, GW and PR.9,33 In general, Churg-Strauss 
syndrome is characterized by asthma, eosinophilia, and ex-
travascular eosinophilic granulomata. Also, as part of the clin-
ical manifestations of CSS, the first phase of this syndrome is 
characterized by asthma possibly associated with allergic rhi-
nitis, and often complicated by nasal polyposis and recurrent 
rhinosinusitis.9 The other phases are manifestations of eo-
sinophilia and/or eosinophilic infiltrates in the tissues (lungs, 
gastrointestinal tract) or of systemic vasculitis.
In the available literature, three stages of the natural his-
tory of CSS are described: (1) prodromal stage, characterized 
by asthma and allergy for several years, (2) eosinophilic stage 
with peripheral blood eosinophilia and an organic infiltrate 
that can decrease or increase over several years, and (3) sys-
temic vasculitis stage, that can be life threatening.30 Still, the 
main feature of ENT manifestations in this disease is an al-
lergic rhinitis associated with nasal polyposis.30,33 According 
to Bacciu et al., allergic rhinitis is present in 42.8% of CSS pa-
tients studied.9
According to literature, in patients with GW, the respira-
tory tract is involved in 70-100 % of cases, with nasal and pa-
ranasal involvement in 80-90 % of cases.4,25,33,34 Chronic nasal 
obstruction with a clear rhinorrhea, nasal ulceration and oe-
dema of the mucosa, besides perforation, erosion of the vo-
mer and nasal deformity with “saddle nose” are classic signs 
of the disease. We can also observe cases of chronic secretory 
otitis media and tympanic membrane perforation, in addi-
tion to the cases described of sensorineural dysacusis, vertigo 
and tinnitus.4,25,33,34 The prevalence of otologic involvement is 
around 35 %, being related to vasculitis and blockage of the 
Table 4 – Other head and neck signs and symptoms
Wegener’s 
granulomatosis n = 17 
Relapsing 
Polychondritis n = 5 
Syndrome of 
Sjögren n = 5 
Systemic Lupus 
Erythematosus n = 3 
Syndrome of 
Churg-Strauss n = 2 
Conjunctivitis 0 1 (20%) 2 (40%) 0 1 (50%)
Headache 3 (18%) 1 (20%) 0 0 1 (50%)
Facial paralysis 0 0 0 0 0
Table 5 – Findings of ENT physical examination
Wegener’s 
granulomatosis n = 17 
Relapsing 
Polychondritis n = 5 
Syndrome of 
Sjögren n = 5 
Systemic Lupus 
Erythematosus n = 3 
Syndrome of 
Churg-Strauss n = 2 
Rhinoscopy, 
change in 
12 (70%) 3 (60%) 5 (100%) 1 (33%) 2 (100%)
Otoscopy,  
change in 
7 (41%) 0 0 0 0
Nasofibroscopy, 
change in
7 (41%) 3 (60%) 4 (80%) 2 (67%) 2 (100%)
Otoscopy,  
change in
7 (41%) 2 (40%) 5 (100%) 1 (33%) 0
Table 6 – Otologic, nasal, and laryngal symptoms and audiometric change in the studied diseases





Wegener’s Granulomatosis 9 (53%) 11 (65%) 7 (41%) 9 (53%)
Relapsing Polychondritis 3 (60%) 2 (40%) 2 (40%) 4 (80%)
Sjögren’s Syndrome 5 (100%) 5 (100%) 3 (60%) 5 (100%)
Systemic Lupus Erythematosus 1 (33%) 1 (33%) 2 (67%) 1 (33%)
Churg-Strauss Syndrome 1 (50%) 2 (100%) 1 (50%) 1 (50%)
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Eustachian tube due to the involvement of nasopharynx.4,25,33,34 
Facial palsy is found in 8-10% of cases and results from vascu-
litis of facial nerve vasa-vasorum, granulomatous invasion of 
middle ear tissue, primary granulomatous lesion of the nerve, 
or a combination of these factors.4,25,33,34 Dysphonia, larynx 
stridor, wheezing, oral ulceration and oedema and gingivitis 
complement the picture of ENT manifestations.4,25,33,34
It is also worth remembering  the important complica-
tions and cardiovascular events in SLE, with risk of fatal 
complications.35 In a transversal trial conducted at Hospital 
Universitário Barros Barreto (HUJBB/UFPA) during 1997-2006, 
the main complication in SLE patients was the infectious 
syndrome (76.4%), followed by renal (33.8%) and thromboem-
bolic (4.2%) events.36 The main sites of infection were pleura 
and lungs (45.4%). The middle ear infection represented 1.8% 
of the cases.36 On the other hand, as a well-documented com-
plication, we can find nasal septum perforation (which can 
manifest with nasal obstruction , epistaxis, posterior nasal 
discharge or crust formation into the nasal cavity), being at-
tributed to local inflammation or ischemia.1 Upper airway 
obstruction due to laryngeal involvement is a rare, but well 
documented, complication of SLE, which usually occurs in 
association with other signs and symptoms that indicate ac-
tive disease.1
Data from the literature show auricular chondritis as the 
most frequent and characteristic finding of the disease, pres-
ent in 85% of cases, and in 40% of them as the initial mani-
festation.8 This condition may be uni- or bilateral, causing 
phlogistic signs, with swelling of the external ear canal, and 
that may lead to conductive hearing loss. Vasculitis of the in-
ternal auditory artery may cause cochlear and/or vestibular 
involvement by cochlear infarct or ischemia, resulting in sen-
sorineural dysacusis.8 Moreover, among the seven diagnostic 
criteria established by McAdam et al., four of them involve 
the presence of symptoms that affect the upper respiratory 
tract or vestibulocochlear system.37
Nasal compromise, arising from nasal chondritis, can re-
sult in a “saddle nose” in up to 50% of patients. The diagnosis 
of laryngo-tracheo-bronchial chondritis is also crucial due to 
its high morbidity and mortality.8 
Xerostomia is a common feature of Sjögren’s syndrome, 
being usual in patients with primary and secondary syn-
drome.38 It is the most obvious symptom of this syndrome.36 
Patients often exhibit dryness of lips, tongue and pharynx 
and consequent painful burning sensation and of mucosa, 
accompanied by speech, chewing, swallowing and digesting 
food difficulty.32 More than one third of patients present sys-
temic manifestations that can include vasculitis, cryoglobu-
linemia, autoimmune hepatitis, pulmonary fibrosis, central 
nervous system involvement, renal tubular acidosis, B-cell 
lymphomas and multiple myeloma.33
Other trials showed oral symptoms of dry mouth in 86% 
and eye symptoms in 53% of patients.39 In the same trial, 
46% of patients exhibited ocular involvement, demonstrated 
by Schirmer test or by Rose Bengal staining; and in 85.7% of 
studied cases an involvement of the salivary gland (by scin-
tigraphy, sialography or sialometry) was evidenced.39 The lit-
erature review shows that the most obvious oral symptom 
is xerostomia, with dryness of lips, tongue and pharynx 
and with chewing, swallowing and speech difficulty, as well 
as increased susceptibility to dental caries and periodontal 
disease.36 About a third to half of patients display an usually 
symmetrical and recurrent parotid gland hypertrophy.40
Finally, we must consider the large time lag between com-
plaints of rheumatology patients and the correct diagnosis, 
already described. The vasculitis involving the airways, for 
example, is a common presentation of a vascular disease 
involving ANCA (anti-neutrophil cytoplasmic antibody) and 
can precede by several years the diagnosis of the disease.33 
One should keep in mind that the referral of patients for 
this trial occurred unevenly among specific rheumatology 
outpatient clinics, according to the aforementioned rheu-
matologic diseases; then, the patients’ distribution does not 
represent the overall distribution of patients with rheumatic 
diseases.
Conclusion
This trial demonstrated the various ENT manifestations of a 
group of patients with rheumatologic diseases that common-
ly can be related to rheumatic diseases, according to other 
trials. The early identification of these symptoms as a mani-
festation of such diseases, both by the otolaryngologist as by 
the rheumatologist, is critical to the early implementation of 
an immunosuppressive treatment, thereby reducing the mor-
bidity and mortality of these conditions.
Conflicts of interest 
The authors declare no conflicts of interest. 
Acknowledgements 
We thank all who contributed to the development of our proj-
ect at the Rheumatology and Otorhinolaryngology, Head and 
Neck disciplines at HC/FCM/UNICAMP. 
R E F E R E N C E S
1. Riera R, Ciconelli RM, Ferraz MB. COPCORD studies. Acta 
Reumatol Port. 2006;31:119-23.
2. Gonzalez-Gay MA, García-Porrua C. Etiopatogenia y 
clasificación e las vasculitis sistémicas. In: Alonso Ruiz A, 
Alvaro-Gracia Alvaro JM, Blanch i Rubio J et al. (Ed.) Manual 
SER de enfermedades reumáticas. 3 ed., Madrid: Médica 
Panamericana. 2000. p. 349-54.
3. Bogas M, Afonso MC, Araújo D. Non-steroidal anti-
inflammatory drugs and lower intestinal tract toxicity.Acta 
Reumatol Port. 2006;31:227-35.
4. Pereira DB, Amaral JLA, Szajubok JCM, Lima SMAL, Chahade 
WH. Otorhinolaryngologic manifestations of autoimmune 
rheumatic diseases. Rev Bras Reumatol. 2006;46:118-25. 
5. Papadimitraki ED, Kyrmizakis DE, Kritikos I, Boumpas DT. 
Ear-nose-throat manifestations of autoimmune rheumatic 
diseases. Clin Exp Rheumatol. 2004; 22:485-94.
6. Oliveira R, Banha J, Martins F, Paixão E, Pereira D, Barcelos F 
et al. Lymphocyte ceruloplasmin and Behçet’s disease. Acta 
Reumatol Port. 2006;31:323-29. 
178 R E V  B R A S  R E U M A T O L .  2 0 1 4 ; 5 4 ( 3 ) : 1 7 2 – 1 7 8
7. Mosiniak-Trajnowicz K, Lis-Ritkiewicz M, Rutkiewicz B, Ginter 
K. Polychondritis relapsans – a case report. Otolaryngol. Pol. 
2006;60:951-53.
8. Carvalho GM, Sachietto Z, Bertolo MB, Gusmão RJ. 
Policondrite recidivante e dispneia. Relato de caso. Rev Bras 
Clin Med. 2011;9:451-54.
9. Bacciu A, Bacciu S, Mercante G, Ingegnoli F, Grosseli C, Vaglio 
A et al. Ear, nose and throat manifestations of Churg-Strauss 
syndrome. Acta Otolaryngol. 2006;126:503-09.
10. Ruckenstein MJ, Prasthoffer A, Begelow DC, Von Feldt JM, 
Kalasinski SL. Immunologic and serologic testing in patients 
with Ménière’s disease. Otol. Neurotol. 2002;23:517-20.
11. Tsunoda K, Akaogi J, Ohya N, Murofushi I. Sensorineural 
hearing loss as the initial manifestation of polyarteritis 
nodosa. J. Otolaryngol. 2001;115:311-12.
12. Hearth-Holmes M, Baethge BA, Alreo F, Wolf RE. Autoimmune 
exocrinopathy presenting as recurrent parotitis of childhood. 
Arch. Otolaryngol Head and Neck Surgery.1993;119:347-49.
13. Camilleri AE, Swan IR, Murphy E, Sturrock RD. Chronic otitis 
media: a new extra-articular manifestation in ankylosing 
spondylitis? Ann Rheumatol. Disease. 1992;51:655-57.
14. Tutuncu Z, Kavanaugh A. Rheumatic disease in the elderly: 
rheumatoid arthritis. Rheum Dis Clin N Am. 2007; 3:57-70.
15. Silva C, Canhão H, Barcelos A, Miranda L, Pinto P, Santos MJ. 
Protocol for evaluation and monitoring of Systemic Lupus 
Erythematosus (PAMLES). Acta Reumatol Port. 2008;33:210-18.
16. Vinagre F, Santos MJ, da Silva JC. Systemic lupus 
erythematosus and weakness. Acta Reumatol Port. 
2006;31:167-72. 
17. Silva L, Sampaio L, Terroso G, Almeida G, Lucas R, Rios E et al. 
Amyloidosis secondary to rheumatic diseases - 16 cases. Acta 
Reumatol Port. 2010;35:518-23.
18. Jennete JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al. 
2012 Revised International Chapel Hill Consensus Conference 
Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1-11.
19. http://www.projetodiretrizes.org.br/projeto_diretrizes/073.
pdf. Acessado em 28 de janeiro de 2011.
20. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP 
et al. The American College of Rheumatology 1990 criteria 
for the classification of Churg-Strauss syndrome (allergic 
granulomatosis and angiitis). Arthritis Rheum. 1990;33:1094-100.
21. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend 
WP et al. The American College of Rheumatology 1990 criteria 
for the classification of Wegener’s granulomatosis. Arthritis 
Rheum. 1990;33:1101-7.
22. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, 
Alexander EL, Carsons SE et al. Classification criteria for 
Sjögren’s syndrome: a revised version of the European 
criteria proposed by the American-European Consensus 
Group. Ann Rheum Dis. 2002;61:554-8 
23. Gergely P Jr, Poor G. Relapsing polychondritis. Best Pract Res 
Clin Rheumatol. 2004 Oct;18:723-38
24. Mourão AF, Oliveira I, Pinheiro MN, da Graça JP. Stroke as 
the dramatic presentation of infectious endocarditis: the 
importance of the clinical history.Acta Reumatol Port. 
2006;31:341-47. 
25. Gomes JM, Gomes SM, Conde M. Autoinflammatory 
syndromes. Acta Reumatol Port. 2010; 35:146-54.
26. Graca L. CTLA4Ig and the therapeutic potential of T cell co-
stimulation blockade.Acta Reumatol Port. 2008;33:267-76.
27. Mourão AF, Santos FP, Falcão S, Barros R, Pinto TL, Mendes A 
et al. Is the response to anti-TNFalpha treatment influenced 
by the presence of IgM rheumatoid factor, in Rheumatoid 
Arthritis patients?. Acta Reumatol Port. 2008;33:430-34. 
28. Carmona L, Ortiz A, Abad MA. How good is to switch between 
biologics? A systematic review of the literature. Acta 
Reumatol Port. 2007;32:113-28. 
29. Gómez-Reino J, Carmona L. Recommendations to lower the 
risk of tuberculosis in patients treated with tumour necrosis 
factor alpha antagonists. Acta Reumatol Port. 2006;31:201-03. 
30. George DL, Pradhan S. Idiopathic sensorineural hearing 
disorders in adults – a pragmatic approach. Nat Rev 
Rheumatol. 2009; 5:505-12. 
31. Zeigelboim BS, Jurkiewicz AL, Palmonari A, Alberti A, Filho 
AR, Ferrari KA. Otoneurological evaluation in women with 
systemic lupus erythematosus: a preliminary study. Arq. Int. 
Otorrinolaringol. 2006;10:126-31.
32. Palombo AAK, Nascimento GM, Filho FAS, Neto JC. Atrofia de 
pregas vocais em paciente com lúpus eritematoso sistêmico: 
relato de caso. ACTA ORL/Técnicas em Otorrinolaringologia. 
2010;2879-80.
33. Del Pero MM, Sivasothy P. Vasculitis of the upper and lower 
airway. Best Practice & Research Clinical Rheumatology. 
2009;23:403-17.
34. Rezende CEB, Rodrigues REC, Yoshimura R, Uvo IP, Rapoport 
PB. Granulomatose de Wegener: relato de caso. Rev Bras 
Otorrinolaringol. 2003;69:261-65.
35. Santos MJ, Vinagre F, Silva JJ, Gil V, Fonseca JE. Cardiovascular 
risk profile in systemic lupus erythematosus and rheumatoid 
arthritis: a comparative study of female patients.Acta 
Reumatol Port. 2010;35:325-32.
36. Conde SRSS, Marçal AS, Tavares GF, Souza HCB, Vasconcelos 
VC. Complicações clínicas em pacientes portadores de lúpus 
eritematoso sistêmico. Rev. Para. Med.; 23, 2009.
37. Guimarães VC, Nery GV, Araújo FGM, Barbosa MA, Ferreira 
JB. Clinical manifestations of Relapsing Polychondritis: case 
report. Rev. Eletr. Enf. 2008;10:823-7.
38. Barcelos F, Patto JV, Parente M, Medeiros D, Sousa M, 
Figueiredo R et al. Applicability of syalometry and other 
instruments to evaluate xerostomia and xerophtalmia in a 
Sjögren’s Syndrome outpatient clinic.Acta Reumatol Port. 
2009;34:212-18. 
39. Liquidato BM, Filho IB, Camargo ACK, Soler RC. Aspectos 
do diagnóstico da Síndrome de Sjögren. Rev. Bras. 
Otorrinolaringol. 2002;68:363-67.
40. Freitas TMC, Medeiros AMC, Oliveira PT, Lima KC. Síndrome 
de Sjögren: revisão de literatura e acompanhamento de um 
caso clínico. Rev Bras Otorrinolaringol. 2004;70283-88.
